The Food and Drug Administration on Friday approved oral dapagliflozin (Farxiga) tablets to slow the progression of chronic kidney disease in adults with and...
Welsh fitness company AFLUENCR, led by founder and CEO Gareth Manger, today announced a multi-million dollar (NZ) acquisition by New Zealand-based MacroActive, the transactional...